RE:RE:RE:RE:RE:RE:Lumeda and NSCLC Yeah Jojo,
The Doctors should be the ones asking if Rutherin proves out for late stage patients. It will be interesting how it all plays out. What will the next IND be? What sort of Dosemetry/Activation/Delivery will it need. Too much speculation. TLT did do a decent job of getting us all up to speed on NMIBC. I expect them to do the same for the next cancer(s).